Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — The etanercept biosimilar, etanercept-szzs, demonstrated an equivalent clinical efficacy and ...

Etanercept is a dimeric, fully human, soluble TNF receptor that binds tightly and specifically to circulating and cell-bound TNF, making it an effective agent for intervention in the PsA inflammatory ...

Please provide your email address to receive an email when new articles are posted on . To determine the efficacy of monotherapy with either methotrexate or etanercept (Enbrel, Amgen), as well as ...

Etanercept, which blocks the action of tumor necrosis factor, reduces disease activity in patients with long-standing rheumatoid arthritis. Its efficacy in reducing disease activity and preventing ...

In final updated guidance published today NICE recommends a number of drugs called biological disease modifying drugs (DMARDs) as options for treating severei rheumatoid arthritis which has not ...

Oct. 14, 2004 — The U.S. Food and Drug Administration (FDA) has approved caspofungin acetate for the empiric treatment of presumed fungal infections in the setting of febrile neutropenia, etanercept ...

Robin Hwang, a senior principal scientist at Amgen (Thousand Oaks, CA), led the team that developed the first commercial disposable auto-injector for a biopharmaceutical: a prefilled three-step ...

Biologic agents offer a range of new therapeutic options for patients with psoriasis; however, the relative benefit–risk profiles of such therapies are not well known. We compared two biologic agents, ...

Abatacept (Orencia, Bristol‑Myers Squibb) is a fusion protein that inhibits the activation of T cells. It is administered by intravenous infusion. Abatacept in combination with methotrexate is ...

Etanercept (Wyeth Pharmaceuticals) is a recombinant human tumour necrosis factor (TNF) receptor fusion protein that inhibits the activity of TNF. TNF is a cytokine that is released from T lymphocytes; ...